Moexipril (DrugBank: Moexipril)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 93 | Primary biliary cholangitis [Primary biliary cirrhosis (~Mar 2017)] | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00588302 (ClinicalTrials.gov) | June 2003 | 22/12/2007 | Moexipril for Primary Biliary Cirrhosis | Open-Label Pilot Investigation of Moexipril for the Treatment of Primary Biliary Cirrhosis (PBC) | Primary Biliary Cirrhosis | Drug: Moexipril | Mayo Clinic | UCB Pharma | Completed | 18 Years | 85 Years | Both | 20 | Phase 2 | United States |